• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】31038

【品名】4-[(Z)-4-phenyl-1-butenyl]-1-trityl-1H-imidazole

【CA登记号】

【 分 子 式 】C32H28N2

【 分 子 量 】440.5878

【元素组成】C 87.24% H 6.41% N 6.36%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(III)

The Wittig condensation of 1-tritylimidazole-4-carbaldehyde (I) with triphenyl(3-phenylpropyl)phosphonium bromide (II) and potassium tert-butoxide in THF gives 4-(4-phenyl-1(Z)-butenyl)-1-trityl-1H-imidazole (III), which is deprotected with 6N HCl in refluxing acetone.

1 Stark, H.; Ligneau, X.; Arrang, J.-M.; Schwartz, J.-C.; Schunack, W.; General construction pattern of histamine H3-receptor antagonists: Change of a paradigm. Bioorg Med Chem Lett 1998, 8, 15, 2011.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 27712 1-trityl-1H-imidazole-4-carbaldehyde;1-Tritylimidazole-4-carboxaldehyde 33016-47-6 C23H18N2O 详情 详情
(II) 31037 triphenyl(3-phenylpropyl)phosphonium bromide 7484-37-9 C27H26BrP 详情 详情
(III) 31038 4-[(Z)-4-phenyl-1-butenyl]-1-trityl-1H-imidazole C32H28N2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(III)

The Wittig condensation of 1-tritylimidazole-4-carbaldehyde (I) with triphenyl(3-phenylpropyl)phosphonium bromide (II) and potassium tert-butoxide in THF gives 4-(4-phenyl-1(Z)-butenyl)-1-trityl-1H-imidazole (III), which is deprotected with 6N HCl in refluxing acetone yielding 4-(4-phenyl-1(Z)-butenyl)-1H-imidazole (IV). Finally, this compound is hydrogenated with H2 over Pd/C in methanol.

1 Stark, H.; Ligneau, X.; Arrang, J.-M.; Schwartz, J.-C.; Schunack, W.; General construction pattern of histamine H3-receptor antagonists: Change of a paradigm. Bioorg Med Chem Lett 1998, 8, 15, 2011.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 27712 1-trityl-1H-imidazole-4-carbaldehyde;1-Tritylimidazole-4-carboxaldehyde 33016-47-6 C23H18N2O 详情 详情
(II) 31037 triphenyl(3-phenylpropyl)phosphonium bromide 7484-37-9 C27H26BrP 详情 详情
(III) 31038 4-[(Z)-4-phenyl-1-butenyl]-1-trityl-1H-imidazole C32H28N2 详情 详情
(IV) 31039 4-[(Z)-4-phenyl-1-butenyl]-1H-imidazole C13H14N2 详情 详情
Extended Information